Surgical Outcomes Research Centre (SOURCE), Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia; Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Colorectal Dis. 2014 Mar;16(3):209-18. doi: 10.1111/codi.12473.
Enterocutaneous fistula (ECF) presents a complex management problem with significant mortality and morbidity. The aim of this study was to assess the outcome of patients undergoing surgical cure for ECF and to predict factors that might relate to increased postoperative morbidity.
Medical records of all patients who underwent definitive surgery for cure of an ECF within our colorectal surgery unit between 2000 and 2010 were reviewed.
Forty-one patients (18 male) were identified, in whom 44 definitive procedures were performed. The median age was 54 (17-81) years. The median postoperative length of stay in hospital was 14 (2-213) days. Half (50%) of the ECFs occurred as a postoperative complication followed by spontaneous fistulation in Crohn's disease (36%). The interval to definitive surgery was influenced by the aetiology of the fistula. The median time to surgery after formation of postoperative fistula was 240 days (7.9 months). There was no 30-day postoperative mortality. There were two (4.5%) recurrences at 3 months. Thirty-eight (86%) patients suffered postoperative morbidity as defined by the Clavien-Dindo classification. High-grade morbidity occurred in 32% of patients. On univariate analysis, factors identified as being significantly associated with high-grade morbidity included a fistula output of > 500 ml/day (P = 0.004) in patients with postoperative ECF, malnutrition at presentation (P = 0.04) and a serum albumin value of < 30 g/l (P = 0.02) in patients with spontaneous ECF due to Crohn's disease.
The majority of persistent complex ECFs can be cured surgically with low mortality and recurrence in a multidisciplinary setting. Postoperative morbidity, however, remains a significant burden.
肠外瘘(ECF)是一种复杂的管理问题,具有显著的死亡率和发病率。本研究旨在评估接受手术治疗 ECF 的患者的结果,并预测可能与术后高发病率相关的因素。
回顾了 2000 年至 2010 年间在我们的结直肠外科病房接受确定性手术治疗 ECF 的所有患者的病历。
确定了 41 名(18 名男性)患者,其中 44 例接受了确定性手术。中位年龄为 54(17-81)岁。术后中位住院时间为 14(2-213)天。一半(50%)的 ECF 是术后并发症引起的,其次是克罗恩病的自发性瘘管(36%)。确定性手术的时间间隔受瘘管病因的影响。术后瘘形成后手术的中位时间为 240 天(7.9 个月)。无 30 天术后死亡。3 个月时有 2 例(4.5%)复发。38 例(86%)患者根据 Clavien-Dindo 分类定义患有术后发病率。高发病率患者占 32%。单因素分析显示,与高发病率显著相关的因素包括术后 ECF 患者瘘管输出量>500ml/天(P=0.004)、初诊时营养不良(P=0.04)和克罗恩病自发性 ECF 患者血清白蛋白值<30g/l(P=0.02)。
在多学科环境下,大多数持续的复杂 ECF 可以通过手术治愈,死亡率和复发率低。然而,术后发病率仍然是一个重大负担。